Charlie Garnett-Benson

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Ejection Fraction

End Stage Renal Disease

Patient Reported

Squamous Cell Carcinoma

Top Venues

Journal for immunotherapy of cancer

Virology journal

This page only lists publications with an associated author ORCID identifier.

Publications

Anne Monette, Sarah H Warren, J Carl Barrett, Charlie Garnett-Benson, Kurt A Schalper, Janis M Taube, Brian Topp, Alexandra Snyder
Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee. Journal for immunotherapy of cancer 12 (7) (2024)
Anne Monette, Sarah H Warren, J Carl Barrett, Charlie Garnett-Benson, Kurt A Schalper, Janis M Taube, Brian Topp, Alexandra Snyder
Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee. Journal for immunotherapy of cancer 12 (7) (2024)
Anne Monette, Sarah H Warren, J Carl Barrett, Charlie Garnett-Benson, Kurt A Schalper, Janis M Taube, Brian Topp, Alexandra Snyder
Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee. Journal for immunotherapy of cancer 12 (7) (2024)
Anne Monette, Sarah H Warren, J Carl Barrett, Charlie Garnett-Benson, Kurt A Schalper, Janis M Taube, Brian Topp, Alexandra Snyder
Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee. Journal for immunotherapy of cancer 12 (7) (2024)
Megan L Dickherber, Charlie Garnett-Benson
NAD-linked mechanisms of gene de-repression and a novel role for CtBP in persistent adenovirus infection of lymphocytes. Virology journal 16 (1) (2019)